Cognition Therapeutics logo

Cognition Therapeutics share price today

(CGTX)

Cognition Therapeutics share price is $0.65 & ₹55.38 as on 25 Dec 2024, 2.30 'hrs' IST

$0.65

0.03

(5.54%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cognition Therapeutics share price in Dollar and Rupees. Guide to invest in Cognition Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Cognition Therapeutics. Get details on the Indian mutual funds that are investing in Cognition Therapeutics. Get Analyst recommendations and forecasts along with all the Cognition Therapeutics's financials.

Cognition Therapeutics share price movements

  • Today's Low: $0.60
    Today's High: $0.67

    Day's Volatility :10.85%

  • 52 Weeks Low: $0.34
    52 Weeks High: $2.95

    52 Weeks Volatility :88.47%

Cognition Therapeutics Returns

PeriodCognition Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
58.05%
-9.0%
0.0%
6 Months
-61.2%
-4.6%
0.0%
1 Year
-65.71%
3.0%
0.0%
3 Years
-89.63%
0.0%
-21.1%

Cognition Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.614
Open
$0.6144
Today's High
$0.6736
Today's Low
$0.6005
Market Capitalization
$26.9M
Today's Volume
$2.8M
52 Week High
$2.95
52 Week Low
$0.34
Revenue TTM
$0.0
EBITDA
$-58.6M
Earnings Per Share (EPS)
$-0.96
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-108.31%

How to invest in Cognition Therapeutics from India?

It is very easy for Indian residents to invest directly in Cognition Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cognition Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cognition Therapeutics or CGTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cognition Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cognition Therapeutics shares which would translate to 1.311 fractional shares of Cognition Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cognition Therapeutics, in just a few clicks!

Returns in Cognition Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cognition Therapeutics investment value today

Current value as on today

₹36,630

Returns

₹63,370

(-63.37%)

Returns from Cognition Therapeutics Stock

₹65,608 (-65.61%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Cognition Therapeutics

1527.27%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Cognition Therapeutics from India has grown in the last 30 days as on Dec 26, 2024. 1527.27% more purchase transactions for Cognition Therapeutics in the last 30 days versus the previous period.

383%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Cognition Therapeutics on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 383% more investors are searching Cognition Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Cognition Therapeutics

  • Vanguard Group Inc

    2.99%

  • Alyeska Investment Group, L.P.

    1.20%

  • Geode Capital Management, LLC

    0.78%

  • CM Management, LLC

    0.60%

  • American Financial Group Inc

    0.49%

  • UBS Group AG

    0.48%

Analyst Recommendation on Cognition Therapeutics

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Cognition Therapeutics(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Cognition Therapeutics

What analysts predicted

Upside of 900.0%

Current:

$0.65

Target:

$6.50

Insights on Cognition Therapeutics

  • Price Movement

    In the last 1 month, CGTX stock has moved up by 60.2%
  • CGTX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 90.4%
  • CGTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 114.7%

Cognition Therapeutics Technicals Summary

Sell

Neutral

Buy

Cognition Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Cognition Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cognition Therapeutics, Inc.
60.2%
-61.2%
-65.71%
-89.63%
-94.93%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cognition Therapeutics, Inc.
NA
NA
NA
-0.85
-1.08
-0.94
NA
0.76
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cognition Therapeutics, Inc.
Buy
$26.9M
-94.93%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Cognition Therapeutics

cognition therapeutics inc. is a drug discovery and development company located in pittsburgh, pennsylvania. founded in 2007, the company uses proprietary biology and chemistry platforms to discover novel drug targets and disease modifying therapies for disorders of the central nervous system.
Organization
Cognition Therapeutics
Employees
25
CEO
Ms. Lisa Ricciardi
Industry
Services

Management People of Cognition Therapeutics

NameTitle
Ms. Lisa Ricciardi
CEO, President & Director
Mr. John Brendan Doyle
Chief Financial Officer
Dr. Anthony O. Caggiano M.D., Ph.D.
Chief Medical Officer and Head of R&D
Dr. Steven A. Weissman Ph.D.
VP & Head of CMC
Ms. Anita Cornet
Head of Quality
Mr. Bobby Horn
Corporate Controller

Important FAQs about investing in Cognition Therapeutics from India :

What is Cognition Therapeutics share price today?

Cognition Therapeutics share price today stands at $0.65, Open: $0.61 ; Previous Close: $0.61 ; High: $0.67 ; Low: $0.60 ; 52 Week High: $2.95 ; 52 Week Low: $0.34. The stock opens at $0.61, after a previous close of $0.61. The stock reached a daily high of $0.67 and a low of $0.60, with a 52-week high of $2.95 and a 52-week low of $0.34.

Can Indians buy Cognition Therapeutics shares?

Yes, Indians can invest in the Cognition Therapeutics (CGTX) from India.

With INDmoney, you can buy Cognition Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cognition Therapeutics at zero transaction cost.

How can I buy Cognition Therapeutics shares from India?

It is very easy to buy Cognition Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cognition Therapeutics be purchased?

Yes, you can buy fractional shares of Cognition Therapeutics with INDmoney app.

What are the documents required to start investing in Cognition Therapeutics stocks?

To start investing in Cognition Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cognition Therapeutics

Today’s highest price of Cognition Therapeutics (CGTX) is $0.67.

Today’s lowest price of Cognition Therapeutics (CGTX) is $0.60.

What is today's market capitalisation of Cognition Therapeutics

Today's market capitalisation of Cognition Therapeutics CGTX is 26.9M

What is the 52 Week High and Low Range of Cognition Therapeutics

  • 52 Week High

    $2.95

  • 52 Week Low

    $0.34

What are the historical returns of Cognition Therapeutics?

  • 1 Month Returns

    60.2%

  • 3 Months Returns

    -61.2%

  • 1 Year Returns

    -65.71%

  • 5 Years Returns

    -94.93%

Who is the Chief Executive Officer (CEO) of Cognition Therapeutics

Ms. Lisa Ricciardi is the current Chief Executive Officer (CEO) of Cognition Therapeutics.